The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study
International Journal of Cancer · 2025
DOI: 10.1002/ijc.70251 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Xuemei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Benzamides, Immunoblastic Lymphadenopathy. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) infection is frequently observed in angioimmunoblastic T‐cell lymphoma (AITL), yet its prognostic and therapeutic implications remain unclear. This multicenter real‐world study analyzed 155 newly diagnosed AITL patients (117 EBV‐encoded RNA‐positive [EBER+] and 38 EBER‐negative [EBER−]) from Chinese institutions between 2012 and 2022. EBER+ cases demonstrated significantly higher Ki67 proliferation indices and CD30 expression compared to EBER− cases ( p = .013 and p = .045, respectively). While no survival difference was observed between EBER+ and EBER− groups (overall survival [OS] p = .16; progression‐free survival [PFS] p = .43), chidamide‐combined chemotherapy significantly improved outcomes exclusively in EBER+ patients (OS p = .014; PFS p = .0018) with no benefit seen in EBER− cases (OS p = .98; PFS p = .83). Multivariate analysis identified distinct risk factors by EBV status. Older age (≥60), thrombocytopenia (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Hematology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Chengdu, China.
- Chengdu Shang Jin Nan Fu Hospital/Shang Jin Hospital of West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Xuemei Wang
Zitieren
APA
Wang, X., Yang, W., Xing, H., Wang, X., Xue, X., Yang, J., & Xu, C. (2025). The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study. International Journal of Cancer. https://doi.org/10.1002/ijc.70251
Vancouver
Wang X, Yang W, Xing H, Wang X, Xue X, Yang J, et al. The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study. International Journal of Cancer. 2025. doi:10.1002/ijc.70251
BibTeX
@article{Wang2025,
author = {Wang, Xuemei and Yang, Wanxi and Xing, Hongyun and Wang, Xiaodong and Xue, Xinyu and Yang, Jiao and Xu, Caigang},
title = {The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.70251}
}
EUVIMED